Literature DB >> 34590263

In Vitro Models for the Study of the Intracellular Activity of Antibiotics.

Frédéric Peyrusson1, Tiep K Nguyen1, Julien M Buyck1,2, Sandrine Lemaire1,3, Gang Wang1, Cristina Seral1,4, Paul M Tulkens1, Françoise Van Bambeke5.   

Abstract

Intracellular bacteria are poorly responsive to antibiotic treatment. Pharmacological studies are thus needed to determine the antibiotics which are the most potent or effective against intracellular bacteria as well as to explore the reasons for poor bacterial responsiveness. An in vitro pharmacodynamic model is described, consisting of (1) phagocytosis of preopsonized bacteria by eukaryotic cells, (2) elimination of noninternalized bacteria with gentamicin, (3) incubation of infected cells with antibiotics, and (4) determination of surviving bacteria by viable cell counting and normalization of the counts based on sample protein content. The use of strains expressing fluorescent proteins under the control of an inducible promoter allows to follow intracellular bacterial division at the individual level and therefore to monitor bacterial persisters that do not multiply anymore.
© 2021. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antibiotic; Efficacy; Gentamicin; Intracellular infection; Opsonization; Phagocytosis; Pharmacodynamics; Relative potency

Mesh:

Substances:

Year:  2021        PMID: 34590263     DOI: 10.1007/978-1-0716-1621-5_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives.

Authors:  Françoise Van Bambeke; Maritza Barcia-Macay; Sandrine Lemaire; Paul M Tulkens
Journal:  Curr Opin Drug Discov Devel       Date:  2006-03

Review 2.  Adherence and invasion of streptococci to eukaryotic cells and their role in disease pathogenesis.

Authors:  Manfred Rohde; G Singh Chhatwal
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.